Xinran Liu is a PhD candidate at the Gastrointestinal Oncology Center, Peking University Cancer Hospital, with core research interests in the basic mechanisms of gastric cancer immunotherapy, cancer precision medicine, and the exploration of multimodal therapy for gastric cancer—key areas that bridge foundational oncology research with clinical treatment innovation. She also holds the National Practicing Physician Qualification Certificate of China, strengthening her ability to link clinical realities to translational research and precision therapy development.

She earned a dual bachelor’s degree: a Bachelor of Clinical Medicine from Nanchang University and a Bachelor of Biomedical Science from Queen Mary University of London, UK. This interdisciplinary background, paired with her clinical qualification, enables her to integrate frontline clinical insights with rigorous biomedical research methodologies—critical for advancing precision medicine and optimizing multimodal therapy strategies for gastric cancer.

Academically, Liu has published multiple first-author papers, showcasing her independent research capabilities in her focus areas. She also participated in translating the renowned Netter Series medical books (English to Chinese), contributing to the dissemination of high-quality global medical knowledge to support clinical and research practice in China. As a core team member, she engages in national and Beijing municipal-level scientific research projects, where she drives the translation of basic research findings (e.g., immunotherapy targets, precision biomarkers) into practical clinical applications—aligning with her long-term goal of accelerating healthcare innovation for gastric cancer patients.

Beyond research, Liu excels in innovation and entrepreneurship, securing over 30 competitive awards (e.g., National Gold Award at the "Internet Plus" China International College Students' Innovation and Entrepreneurship Competition, First Prize at the National Life Science Innovation and Entrepreneurship Competition).

To expand her global academic perspective, Liu participated in prestigious exchange programs at the National University of Singapore and the University of California, Berkeley. She further enhanced her expertise in cutting-edge healthcare technologies by completing a joint Peking University-Stanford University course on "AI and Generative Models in Healthcare," equipping her to integrate emerging technologies (e.g., AI-driven precision diagnosis) with her oncology research and clinical practice.